Funding opportunties

Check back here regularly for new funding opportunities. Please get in touch with us to discuss potential collaborations.

NIHR Efficacy and Mechanism Evaluation Programme: Mitigation of the adverse effects of health and social care interventions

Stage 1 applications are invited for this call on the ‘Mitigation of the adverse effects of health and social care interventions’.

Areas of interest include, but are not limited to:

  • Novel interventions to reduce adverse effects (e.g. to stop misprescribing)
  • Novel interventions to identify patients at increased risk of adverse effects
  • Studies to stratify patients to an established treatment that has very severe adverse effects
  • Development of health technologies which promise an improved safety profile.
  • Additive interventions which may improve the safety profile of existing technologies
  • Pharmacogenomic strategies to mitigate the risks of exaggerated or diminished drug responses.

Deadline:  1pm on 16th April 2020

The EME programme will run a webinar to support applications for this call on Tuesday 21st January, 12-1pm.

This funding call relates to the NCRI LWBC James Lind Alliance Priority #6: “How can the short-term, long-term and late effects of cancer treatments be a) prevented and/or b) best treated/managed?

Click here for more information

Cancer Research UK: Children and Young People’s Cancer Innovation Award

The Children and Young People’s Cancer Innovation Award is a new initiative to support novel and innovative approaches to childhood cancer research. 

Amount: £1m, up to 3 years 

Closing date: Friday 10th January 2020 

Click here for more information

 

PHIND: Systems based approaches to Public Health intervention development

This call seeks to:

  • Encourage the development of innovative, novel and scalable interventions which address an important UK or global public health issue
  • Support the development of population-level interventions
    “Population” is defined as a group of individuals an intervention may take place within, for example, schools, prisons, or larger communities and regions
    Examples of the focus of population-level interventions include transport, education, employment, leisure and the built environment

Closing date: 22 Jan 2020 16:00 GMT

Click here for more information 

 

MRC:

Tackling multimorbidity at scale: Understanding disease clusters, determinants & biological pathways 

Amount: Consolidator grant up to £100k; Research Collaborative award up to £5m

Deadline: 11 February 2020

  • Identify and describe new disease clusters
  • Multimorbidity at different stages of the life course
  • Uncovering, validating and targeting shared determinants and mechanistic pathways
  • Early detection/prediction

Click here for more information

Copyright © 2020 | All Rights Reserved